In the News

1691 News Items found
MSK molecular geneticist Elli Papaemmanuil.
Large International Study Pinpoints Impact of TP53 Gene Mutations on Blood Cancer Severity
Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering.
Joan Massagué, PhD
Spotlight Speaker: SKI Director, Joan Massagué, PhD
SKI Director, Joan Massagué, PhD, is an internationally renowned cancer biologist and leading researcher in the study of cancer metastasis. He is featured in the July 29 MSK Science Spotlight.
MSK Physician-in-Chief Lisa DeAngelis
U.S. News & World Report Ranks MSK in 8 Subspecialties
MSK was recognized in several areas of patient care in this year’s U.S. News & World Report annual listing of best hospitals.
Alexander Rudensky, PhD
Shining a Spotlight on Pioneering Immunologist, Alexander Rudensky, PhD
The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD.
Dr. Lisa DeAngelis
Cancer Is Not Going Away During COVID-19: Physician-in-Chief Lisa DeAngelis Shares Why Patients Need to Get Back to the Clinic
Cancer institutions need to be vigilant in their approach to getting patients safely back to the clinic so they don’t further delay life-saving care.
Section of a lung cancer tumor in mice
A Never-Before-Seen Cell State May Explain Cancer’s Ability to Resist Drugs
Identified in mice, this unusual cell state emerges early during tumor evolution and gives tumors enormous malleability.
MSK Kids staff work on making the “We’re All in This Together” prom video
MSK Kids and Staff Dance Through 2020 with a “Mask-erade” Prom
MSK Kids staff made some clever tweaks and a few adjustments to host the ultimate “mask-erade” prom.
Luis Diaz, MD
Spotlight on Immunotherapy of Mismatch Repair Deficient Tumors
The July 22 MSK Science Spotlight features Luis Diaz, MD, Head of the Division of Solid Tumor Oncology and Grayer Family Chair, presenting his work on ”Immunotherapy of Mismatch Repair Deficient Tumors.”
In the Clinic
Medical oncologist William Tap speaks with a patient.
What’s New in Sarcoma Treatment? MSK Researchers Are Leading Many Innovative Clinical Trials
MSK’s sarcoma team is dedicated to developing new approaches for treating people with this rare cancer.
David Jones
Lung Health in the Time of COVID-19
MSK experts shared their insights on lung cancer, screening and general lung health in an Information Session for patients, caregivers and those at increased risk for the disease.